LEADER 05564nam 2200721Ia 450 001 9910456641103321 005 20200520144314.0 010 $a0-19-959876-2 010 $a1-283-58192-2 010 $a9786613894373 010 $a0-19-155169-4 035 $a(CKB)2430000000023032 035 $a(EBL)975533 035 $a(OCoLC)801363624 035 $a(SSID)ssj0000353440 035 $a(PQKBManifestationID)12087760 035 $a(PQKBTitleCode)TC0000353440 035 $a(PQKBWorkID)10301917 035 $a(PQKB)10557379 035 $a(StDuBDS)EDZ0000091425 035 $a(MiAaPQ)EBC975533 035 $a(Au-PeEL)EBL975533 035 $a(CaPaEBR)ebr10581437 035 $a(CaONFJC)MIL389437 035 $a(EXLCZ)992430000000023032 100 $a20081022d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aOxford handbook of clinical haematology$b[electronic resource] /$fDrew Provan ... [et al.] 205 $a3rd ed. 210 $aOxford ;$aNew York $cOxford University Press$d2009 215 $a1 online resource (880 p.) 225 1 $aOxford handbooks 225 1 $aOxford medical publications 300 $aDescription based upon print version of record. 311 $a0-19-922739-X 320 $aIncludes bibliographical references and index. 327 $aContents; Acknowledgements; Contributors; Symbols and abbreviations; 1 Clinical approach; History taking in patients with haematological disease; Physical examination; Splenomegaly; Lymphadenopathy; Unexplained anaemia; Patient with elevated haemoglobin; Elevated WBC; Reduced WBC; Elevated platelet count; Reduced platelet count; Easy bruising; Recurrent thromboembolism; Pathological fracture; Raised ESR; Serum or urine paraprotein; Anaemia in pregnancy; Thrombocytopenia in pregnancy; Prolonged bleeding after surgery; Positive sickle test (HbS solubility test); 2 Red cell disorders 327 $aThe peripheral blood film in anaemiasAnaemia in renal disease; Anaemia in endocrine disease; Anaemia in joint disease; Anaemia in gastrointestinal disease; Anaemia in liver disease; Iron (Fe) deficiency anaemia; Vitamin B[sub(12)] deficiency; Folate deficiency; Other causes of megaloblastic anaemia; Anaemia in other deficiency states; Haemolytic syndromes; Genetic control of haemoglobin production; Sickling disorders; HbS-new therapies; Sickle cell trait (HbAS); Other sickling disorders; Other haemoglobinopathies; Unstable haemoglobins; Thalassaemias; ? thalassaemia; ? thalassaemia 327 $aOther thalassaemiasHereditary persistence of fetal haemoglobin; Hb patterns in haemoglobin disorders; Non-immune haemolysis; Hereditary spherocytosis; Hereditary elliptocytosis; Glucose-6-phosphate dehydrogenase (G6PD) deficiency; Pyruvate kinase (PK) deficiency; Other red cell enzymopathies; Drug-induced haemolytic anaemia; Methaemoglobinaemia; Microangiopathic haemolytic anaemia (MAHA); Acanthocytosis; Autoimmune haemolytic anaemia; Cold haemagglutinin disease (CHAD); Leucoerythroblastic anaemia; Aplastic anaemia; Paroxysmal nocturnal haemoglobinuria; Pure red cell aplasia 327 $aIron (Fe) overloadTransfusion haemosiderosis; 3 White blood cell abnormalities; Neutrophilia; Neutropenia; Lymphocytosis and lymphopenia; Eosinophilia; Basophilia and basopenia; Monocytosis and monocytopenia; Mononucleosis syndromes; 4 Leukaemia; Acute myeloblastic leukaemia (AML); Acute lymphoblastic leukaemia (ALL); Chronic myeloid leukaemia (CML); Chronic lymphocytic leukaemia (B-CLL); Cell markers in chronic lymphoproliferative disorders; Prolymphocytic leukaemia (PLL); Hairy cell leukaemia and variant; Splenic marginal zone lymphoma (SMZL); Mantle cell lymphoma (MCL) 327 $aLarge granular lymphocyte leukaemia (LGLL)Adult T-cell leukaemia-lymphoma (ATL); Se?zary syndrome (SS); 5 Lymphoma; Non-Hodgkin lymphoma (NHL); Indolent lymphoma; Treatment of indolent lymphoma; Aggressive lymphomas; Initial treatment of aggressive lymphomas; CNS lymphoma; Hodgkin lymphoma (HL, Hodgkin's disease); 6 Myelodysplasia; Myelodysplastic syndromes (MDS); Classification; Clinical features of MDS; Diagnostic criteria of MDS; Prognostic factors in MDS; Clinical variants of MDS; Management of MDS; Response criteria; Myelodysplastic/myeloproliferative diseases (MDS/MPD) 327 $a7 Myeloproliferative neoplasms (MPNs) 330 $aThe Oxford Handbook of Clinical Haematology continues to provide the essential knowledge needed in modern clinical practice for the diagnosis and management of patients with disorders of the blood. Major advances in the specialty, primarily within the malignant haematology area, have been reflected in this thoroughly revised new edition. Agencies such as NICE have influenced the prescribing of chemotherapeutic and other related drugs, and there have also been updates from theBritish Committee for Standards in Haematology and other guidelines for malignant disease, thrombosis and haemostasis.Th 410 0$aOxford handbooks. 410 0$aOxford medical publications. 606 $aBlood$xDiseases$vHandbooks, manuals, etc 606 $aHematology 608 $aElectronic books. 615 0$aBlood$xDiseases 615 0$aHematology. 676 $a616.1/5 701 $aProvan$b Drew$f1955-$0870829 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456641103321 996 $aOxford handbook of clinical haematology$91944117 997 $aUNINA